- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Melanoma proteomics suggests functional differences related to mutational status ; volume:9 ; number:1 ; day:10 ; month:5 ; year:2019 ; pages:1-7 ; date:12.2019
Scientific reports ; 9, Heft 1 (10.5.2019), 1-7, 12.2019
- Creator
-
Trilla-Fuertes, Lucía
Gámez-Pozo, Angelo
Prado-Vázquez, Guillermo
Zapater-Moros, Andrea
Díaz-Almirón, Mariana
Fortes, Claudia
Ferrer-Gómez, María
López-Vacas, Rocío
Parra Blanco, Verónica
Márquez-Rodas, Iván
Soria, Ainara
Fresno Vara, Juan Ángel
Espinosa, Enrique
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-43512-z
- URN
-
urn:nbn:de:101:1-2019072404100152963954
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Trilla-Fuertes, Lucía
- Gámez-Pozo, Angelo
- Prado-Vázquez, Guillermo
- Zapater-Moros, Andrea
- Díaz-Almirón, Mariana
- Fortes, Claudia
- Ferrer-Gómez, María
- López-Vacas, Rocío
- Parra Blanco, Verónica
- Márquez-Rodas, Iván
- Soria, Ainara
- Fresno Vara, Juan Ángel
- Espinosa, Enrique
- SpringerLink (Online service)
Other Objects (12)
Sex differences in oncogenic mutational processes
Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Gender differences and outcome of melanoma patients
Gender Differences and Outcomes in Melanoma Patients
Novel FFPE proteomics method suggests prolactin induced protein as hormone induced cytoskeleton remodeling spatial biomarker
Comparative proteomics of the two T. brucei PABPs suggests that PABP2 controls bulk mRNA
Positional proteomics reveals differences in N‐terminal proteoform stability
Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma
Mutational landscape differences between young-onset and older-onset breast cancer patients
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
Sex differences in oncogenic mutational processes
Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Gender differences and outcome of melanoma patients
Gender Differences and Outcomes in Melanoma Patients
Novel FFPE proteomics method suggests prolactin induced protein as hormone induced cytoskeleton remodeling spatial biomarker
Comparative proteomics of the two T. brucei PABPs suggests that PABP2 controls bulk mRNA
Positional proteomics reveals differences in N‐terminal proteoform stability
Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma
Mutational landscape differences between young-onset and older-onset breast cancer patients
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
Sex differences in oncogenic mutational processes
Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
Gender differences and outcome of melanoma patients
Gender Differences and Outcomes in Melanoma Patients
Novel FFPE proteomics method suggests prolactin induced protein as hormone induced cytoskeleton remodeling spatial biomarker
Comparative proteomics of the two T. brucei PABPs suggests that PABP2 controls bulk mRNA
Positional proteomics reveals differences in N‐terminal proteoform stability
Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma
Mutational landscape differences between young-onset and older-onset breast cancer patients